According to our findings, CD4 + T cells and CD8 + T cells that co-express PD-1 and TIM3 were substantially more prevalent in SLE patients with LN, elevated disease activity, C3 depression, and anti-dsDNA antibodies nevertheless diminished following immunotherapy. This evidence concerns the gene HAVCR2 and systemic lupus erythematosus.